-
公开(公告)号:US11364254B2
公开(公告)日:2022-06-21
申请号:US16561990
申请日:2019-09-05
IPC分类号: A61K31/7048 , A23L33/105 , A23L33/12 , A23L33/19 , A23L33/17 , A61K31/352 , A61K45/06 , A23L33/00 , A61K31/202 , A61K38/17 , A61K38/00 , A61K31/12 , A61K31/353
摘要: A composition comprising one or more polyphenols, such as oleuropein, rutin, curcumin or quercetin, can treat or prevent sarcopenia, reduce a loss of muscle functionality (e.g. muscle strength, gait speed, etc.), increase muscle functionality, and/or improve recovery of muscle functionality after muscle atrophy. The composition can be administered to an individual who is elderly and/or frail.
-
公开(公告)号:US20200368266A1
公开(公告)日:2020-11-26
申请号:US16992928
申请日:2020-08-13
IPC分类号: A61K31/7048 , A23L33/105 , A23L33/12 , A61K31/12 , A23L33/19 , A23L33/17 , A61K31/352 , A61K45/06 , A23L33/00 , A61K31/202 , A61K31/353 , A61K38/17
摘要: A composition comprising one or more polyphenols, such as oleuropein, rutin, curcumin or quercetin, can treat or prevent sarcopenia, reduce a loss of muscle functionality (e.g. muscle strength, gait speed, etc.), increase muscle functionality, and/or improve recovery of muscle functionality after muscle atrophy. The composition can be administered to an individual who is elderly and/or frail.
-
公开(公告)号:US20200316094A1
公开(公告)日:2020-10-08
申请号:US16870224
申请日:2020-05-08
IPC分类号: A61K31/593 , A61K31/05 , A61K31/592 , A61K31/351 , A23L33/155 , A23L33/16 , A61K31/7048 , A61K45/06 , A61K47/02
摘要: The present invention relates to use of a composition for maintenance of bone and/or cartilage health or prevention, alleviation and/or treatment of bone and/or cartilage disorders.
-
公开(公告)号:US11166965B2
公开(公告)日:2021-11-09
申请号:US16870224
申请日:2020-05-08
IPC分类号: A61K31/593 , A61K31/05 , A61K31/592 , A61K31/351 , A23L33/155 , A23L33/16 , A61K31/7048 , A61K45/06 , A61K47/02
摘要: The present invention relates to use of a composition for maintenance of bone and/or cartilage health or prevention, alleviation and/or treatment of bone and/or cartilage disorders.
-
公开(公告)号:US11813273B2
公开(公告)日:2023-11-14
申请号:US16992928
申请日:2020-08-13
IPC分类号: A61K31/7048 , A23L33/105 , A23L33/12 , A61K31/12 , A23L33/19 , A23L33/17 , A61K31/352 , A61K45/06 , A23L33/00 , A61K31/353 , A61K38/17 , A61K38/00 , A61K31/202
CPC分类号: A61K31/7048 , A23L33/105 , A23L33/12 , A23L33/17 , A23L33/19 , A23L33/40 , A61K31/12 , A61K31/202 , A61K31/352 , A61K31/353 , A61K38/1709 , A61K45/06 , A23V2002/00 , A61K38/00 , A23V2002/00 , A23V2200/316 , A23V2250/1868 , A23V2250/2116 , A23V2250/21168 , A23V2250/2117
摘要: A composition comprising one or more polyphenols, such as oleuropein, rutin, curcumin or quercetin, can treat or prevent sarcopenia, reduce a loss of muscle functionality (e.g. muscle strength, gait speed, etc.), increase muscle functionality, and/or improve recovery of muscle functionality after muscle atrophy. The composition can be administered to an individual who is elderly and/or frail.
-
公开(公告)号:US20240082281A1
公开(公告)日:2024-03-14
申请号:US18220541
申请日:2023-07-11
IPC分类号: A61K31/7028 , A61K31/12 , A61K31/121 , A61K31/7016 , A61K31/7048 , A61K45/06
CPC分类号: A61K31/7028 , A61K31/12 , A61K31/121 , A61K31/7016 , A61K31/7048 , A61K45/06
摘要: Compositions for treatment or prevention of synovitis are provided. The compositions contain a therapeutically effective amount of at least one of oleuropein, rutin or curcumin and preferably contain at least oleuropin. Methods for treatment or prevention of synovitis are also provided, and the methods include administering such compositions. The compositions can additionally include one or more of quercetin, hydroxytyrosol or vitamin D.
-
公开(公告)号:US20200061094A1
公开(公告)日:2020-02-27
申请号:US16561990
申请日:2019-09-05
IPC分类号: A61K31/7048 , A23L33/105 , A23L33/12 , A61K31/12 , A23L33/19 , A61K31/202 , A61K31/353 , A61K38/17 , A23L33/17 , A61K31/352 , A61K45/06 , A23L33/00
摘要: A composition comprising one or more polyphenols, such as oleuropein, rutin, curcumin or quercetin, can treat or prevent sarcopenia, reduce a loss of muscle functionality (e.g. muscle strength, gait speed, etc.), increase muscle functionality, and/or improve recovery of muscle functionality after muscle atrophy. The composition can be administered to an individual who is elderly and/or frail.
-
-
-
-
-
-